CASI Pharmaceuticals (CASI) Other Non Operating Income (2022 - 2025)
Historic Other Non Operating Income for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to -$415000.0.
- Pharmaceuticals' Other Non Operating Income fell 25660.38% to -$415000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$531000.0, marking a year-over-year decrease of 31673.47%. This contributed to the annual value of -$192000.0 for FY2024, which is 19600.0% down from last year.
- According to the latest figures from Q2 2025, Pharmaceuticals' Other Non Operating Income is -$415000.0, which was down 25660.38% from -$146000.0 recorded in Q1 2025.
- In the past 5 years, Pharmaceuticals' Other Non Operating Income registered a high of $5.6 million during Q4 2022, and its lowest value of -$637000.0 during Q3 2022.
- Over the past 4 years, Pharmaceuticals' median Other Non Operating Income value was -$149500.0 (recorded in 2023), while the average stood at $422100.0.
- Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 8228.23% in 2023, then plummeted by 29830.51% in 2024.
- Quarter analysis of 4 years shows Pharmaceuticals' Other Non Operating Income stood at $5.6 million in 2022, then crashed by 93.39% to $368000.0 in 2023, then fell by 27.99% to $265000.0 in 2024, then plummeted by 256.6% to -$415000.0 in 2025.
- Its Other Non Operating Income was -$415000.0 in Q2 2025, compared to -$146000.0 in Q1 2025 and $265000.0 in Q2 2024.